Cleared Traditional

MirrorMe3D Modeling System (K212981) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K212981 · Mirrorme3D, LLC · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2022
Decision
217d
Days
Class 2
Risk

K212981 is an FDA 510(k) clearance for the MirrorMe3D Modeling System. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Mirrorme3D, LLC (New York, US). The FDA issued a Cleared decision on April 22, 2022 after a review of 217 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Mirrorme3D, LLC devices

Submission Details

510(k) Number K212981 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 17, 2021
Decision Date April 22, 2022
Days to Decision 217 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
110d slower than avg
Panel avg: 107d · This submission: 217d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 809
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K212981.
aPROMISE X
K220590 · Exini Diagnostics AB · Apr 2022
Oryx Cloud Imaging
K220684 · Oryx Dental Software, Inc. · Apr 2022
AngioCloud Service
K211713 · Angiocloud, LLC · Apr 2022
XD
K220779 · Mirada Medical, Ltd. · Apr 2022
TeleScan
K220767 · Bb Imaging · Apr 2022
ClariPulmo
K203783 · Claripi, Inc. · Apr 2022